The laboratory of Dr. Olivier George is seeking applicants for a postdoctoral position available now in the Department of Psychiatry at the University of California, San Diego. The successful applicant will receive training under NIAAA- and/or NIDA-funded research programs (R01/U01) as well as the NIAAA T32 training grant (depending on eligibility).
This solicitation seeks applicants who have an interest in the neurobiological basis of drug, nicotine, and alcohol use disorders, including but not limited to identification and characterization of the genetic, molecular, and neuronal mechanisms that underlie compulsive drug use.
Candidates must have a PhD in neuroscience, pharmacology or biomedical sciences. Expertise with behavioral pharmacology and stereotaxic surgeries is required. Additional experience with patch-clamp electrophysiology, opto/chemogenetics, IV self-administration, and/or brain imaging techniques are recommended.
An ability to think critically and creatively, along with strong writing and communication skills, is essential.
The successful candidate should be able to work independently, participate in large-scale studies that involve multiple teams, and be willing to collaborate with lab members and other groups in the Department of Psychiatry and Skaggs School of Pharmacy and Pharmaceutical Sciences.
Qualified applicants should apply here:
Internal Number: OG201901
About Olivier George
Olivier George, Ph.D. is an Associate Professor at the University of California San Diego, School of Medicine in the department of Psychiatry. He serves as the Co-Director of the Animal Core of the Scripps Research Alcohol Research Center, and Director of the Cocaine and Oxycodone Biobanks. Dr. George received his Ph.D. from the University of Bordeaux (France) where he worked with Drs. Le Moal, Piazza and Mayo on the role of cholinergic neurons in age-related sleep and memory impairments. He went on to conduct postdoctoral work on animal models of addiction at The Scripps Research Institute in La Jolla with Dr. Koob, before joining the faculty in 2013. He has studied alcohol, nicotine and drug addiction for more than 15 years, starting with his postdoctoral studies that were the first to identify the role of corticotropin releasing factor in escalation of nicotine self-administration and demonstrating that escalation of cocaine, methamphetamine and alcohol intake produces a dysfunction of the prefrontal cortex leading to cognitive impairment. Dr. George has made several breakthrough discoveries including identifying the neuronal ensembles of alcohol and nicotine addiction and disco...vering a novel neuronal population that drives negative emotional states in nicotine addiction. Dr. George has also pioneered the development of novel animal models of nicotine, opioid and alcohol addiction using electronic cigarette vapor self-administration. His recent work focuses on unveiling the genetic basis of addiction and identifying brain-wide functional architecture remodeling in animal models of drug addiction using single-cell whole brain imaging. His studies span multiple levels of approaches from molecular to integrated systems using state-of-the-art animal models of addiction with strong translational relevance. Using these approaches, he has contributed to the development of several Investigational New Drugs and hold several patents. He has given over 115 talks to audiences of all levels, from high school, undergraduate and graduate students, to the general public and scientific colleagues in the field. Dr. George has published more than 70 papers in peer-reviewed journals. His work is supported by the National Institute on Drug Abuse (NIDA), the National Institute on Alcohol and Alcoholism (NIAAA), the Tobacco-Related Disease Research Program (TRDRP).
We believe that good health is the cornerstone of progress. We are firm in our resolve to make exemplary health care accessible and affordable to all, dedicated to lowering the high rate of cardiovascular disease, including stroke, in minority populations and committed to advocacy and diversity. We are guided by ethical principles in all transactions and strive for excellence in our training and skills.